{"entity":{"id":"christian-singer","kind":"person","name":"Christian Singer","aka":[],"tldr":"Gynaecological oncologist at the Medical University of Vienna and ABCSG Vice-President, known for work on breast cancer and hereditary cancer risk.","summary":"Christian Singer is Vice-President of the Austrian Breast & Colorectal Cancer Study Group and heads the breast health centre at the Medical University of Vienna's Department of Obstetrics and Gynaecology. His research covers breast cancer treatment, BRCA-associated hereditary breast and ovarian cancer, and translational biomarker studies within ABCSG trials.","asOf":"2026-09-10","links":[{"label":"Society page","url":"https://www.abcsg.org/en/about-us/board/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Singer+CF%5BAuthor%5D"}],"tags":["leadership","clinician-scientist","breast cancer","hereditary cancer"],"related":[],"cancers":["breast-hr-positive","ovarian"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["abcsg"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["journal-of-experimental-and-clinical-cancer-research"],"dependsOn":[],"notes":[],"role":"Vice-President","institutionId":"abcsg","specialisms":["Breast cancer","Gynaecological oncology","Hereditary cancer"],"profiles":[{"label":"Society page","url":"https://www.abcsg.org/en/about-us/board/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Singer+CF%5BAuthor%5D"}],"papers":[{"title":"Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)","journal":"European Journal of Cancer","year":2020,"doi":"10.1016/j.ejca.2020.03.018"},{"title":"Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial","journal":"Nature Cancer","year":2025,"doi":"10.1038/s43018-024-00890-2"},{"title":"Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients","journal":"Journal of Experimental & Clinical Cancer Research","year":2023,"doi":"10.1186/s13046-023-02876-x"}]},"route":"/people/christian-singer/","neighbours":{"cancer":[{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"}],"company":[{"id":"abcsg","kind":"company","name":"Austrian Breast & Colorectal Cancer Study Group","route":"/companies/abcsg/"}],"journal":[{"id":"journal-of-experimental-and-clinical-cancer-research","kind":"journal","name":"Journal of experimental & clinical cancer research","route":"/journals/journal-of-experimental-and-clinical-cancer-research/"}]}}